Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Knudsen (Bergen, Norway), R. Nielsen (Bergen, Norway), I. Haaland (Bergen, Norway), S. Lehmann (Bergen, Norway), T. Eagan (Bergen, Norway). The lower airways microbiome in patients with IPF and COPD. 1326

Member's Comments

No comment yet.

Related content which might interest you: The study of airway microbiome and mycobiome of COPD and AECOPD patients Source: International Congress 2018 – Studies on the mechanisms underlying airway disease Year: 2018 A study of the airway mycobiome in COPD patients and controls Source: International Congress 2019 – Novel molecular pathways in lung cancer and COPD Year: 2019 Is lung emphysema in COPD patients reflected by central airways inflammation? Source: Eur Respir J 2003; 22: Suppl. 45, 207s Year: 2003 The airway microbiota and exacerbations of COPD Source: ERJ Open Res, 6 (3) 00168-2020; 10.1183/23120541.00168-2020 Year: 2020 The pulmonary microbiome and immunological activity in IPF patients. Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis Year: 2020 The microbiome in IPF Source: International Congress 2014 – ERS/NEJM joint lunchtime session "The changing landscape of idiopathic pulmonary fibrosis (IPF)" Year: 2014 The clinical importance of small airway involvement in patients with asthma and COPD Source: International Congress 2019 – PG12 Recent advances in small airways diseases in patients with asthma and COPD Year: 2019 The lung deposition of tiotropium in COPD patients is comparable to that in healthy subjects and independent of the stage of COPD disease Source: Eur Respir J 2003; 22: Suppl. 45, 51s Year: 2003 Pathology of small airways in non-COPD smokers with low diffusion capacity and patients with COPD Source: Virtual Congress 2020 – Phenotypes of obstructive diseases Year: 2020 Neutrophil elastase levels in sputum of patients with different airway diseases: COPD, bronchiectasis and asthma Source: Eur Respir J 2002; 20: Suppl. 38, 95s Year: 2002 The effect of exacerbations on the airway microbiota in children with non-CF bronchiectasis Source: International Congress 2019 – A mixture of rare lung diseases Year: 2019 Airway pathology in COPD compared to that in smokers with asthma Source: Annual Congress 2008 - Smokers with asthma versus COPD: differences and similarities Year: 2008 Upper and lower airway pathogens at exacerbation of COPD Source: Eur Respir J 2005; 26: Suppl. 49, 250s Year: 2005 Lung comparative function in COPD patients and in patients with chronic airflow obstruction due to tuberculosis lung disorder Source: Eur Respir J 2006; 28: Suppl. 50, 130s Year: 2006 Increased circulating alveolar epithelial microparticles in COPD patients Source: International Congress 2015 – Modulating the immune system in COPD and asthma Year: 2015 COPD and asthma overlap with bronchiectasis Source: Eur Respir Monogr 2018; 81: 167-185 Year: 2018 The relationship between fibroblasts and airway structure in patients with asthma and chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 148s Year: 2001 Role of neutrophils in airway inflammation in patients with pneumoconiosis and COPD Source: Eur Respir J 2004; 24: Suppl. 48, 322s Year: 2004 Lung microbiome dynamics in COPD exacerbations Source: Eur Respir J 2016; 47: 1082-1092 Year: 2016